Machine Learning Digs Up a Treasure Trove of Antimicrobial Peptides
Antimicrobial resistance (AMR) is one of the world’s urgent public health problems. New therapeutics and strategies are needed to contend with the growing number of resistant superbugs. Now, scientists at the Queensland University of...
Virginia Tech researcher helps reach nutrition security goals
Food is many things.
Credit: Photo by Max Esterhuizen for Virginia Tech.
Food is many things.
It nourishes our bodies, delights our senses, and gives us something to gather around. Food is also a powerful cultural symbol,...
UMass Amherst to join $90M US National Science Foundation large-scale research infrastructure for education
June 4, 2024
Credit: UMass Amherst
June 4, 2024
UMass Amherst to Join $90M US National Science Foundation large-scale research infrastructure for education
Platform brings together institutions, digital learning and a world-class team to enable research studies to...
5-Cog paradigm: A breakthrough in dementia diagnosis and care
The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine. A new study, published today in Nature Medicine, finds that an easy, five-minute assessment paired with recommendations built...
Using iPSCs as Starting Material for Advanced Therapies
Induced pluripotent stem cells (iPSCs) are a “starting material grail” for advanced therapies. That’s according to Sven Kili, chief development officer at CCRM, the Canadian regenerative medicine accelerator. Kili, who spoke about future trends...
Applied Cells releases game-changing reagent kits to empower cell therapy development
Applied Cells is excited to announce the launch of its MARS® Ingenuity™ Reagent kits for fast and easy cell isolation. This innovative product line features both RUO and GMP-grade reagents, and has been specifically optimized for use on Applied...
Two-pronged attack strategy boosts immunotherapy in preclinical studies
JUNE 3, 2024, NEW YORK – A novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged attack against solid tumors to boost the immune system’s ability to target and eliminate cancer...
Neoadjuvant Immunotherapy for Melanoma Shows Promise in Phase III Study
Newly reported data from a Phase III trial led by researchers at the Netherlands Cancer Institute demonstrated the success of immunotherapy before surgery (neoadjuvant therapy) for patients with metastatic melanoma, supporting data from previous...
Thyroid eye disease patients experience lasting improvements after treatment with teprotumumab
Most patients with thyroid eye disease treated with teprotumumab didn't require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston,...
Cervix on a Chip Latest Advance for Women’s Health
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the University of California, Davis, have developed a microfluidic model of the human cervix. This “Cervix-on-a-Chip” (Cervix Chip) replicates the epithelial-stromal...
